Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M44.5Revenue $M1.0Net Margin (%)-4,967.2Altman Z-Score-31.8
Enterprise Value $M43.4EPS $-0.5Operating Margin %-4,750.7Piotroski F-Score5
P/E(ttm)--Beneish M-Score-2.3Pre-tax Margin (%)-4,897.8Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %-16.6Quick Ratio1.7Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-30.3Current Ratio1.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-106.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-706.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M105ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with STEM

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

STEM is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


STEM: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about STEM:

News about STEM:

Articles On GuruFocus.com
Billionaires Hold Waning Biotechs 42% Off Oct 16 2013 
comment on STEM Feb 09 2012 
Two Biotech Stocks to Buy, One to Avoid Jan 09 2012 
StemCells Inc. Reports Operating Results (10-Q) Nov 03 2010 
StemCells Inc. Reports Operating Results (10-Q) May 04 2010 
StemCells Inc. Reports Operating Results (10-Q) Nov 05 2009 
StemCells, Inc. Reports Second Quarter Financial Results Aug 10 2009 
StemCells Inc. Reports Operating Results (10-Q) Aug 10 2009 
The Next Boom Emerges Nov 23 2008 

More From Other Websites
StemCells to Rebound From Suit Dismissal Jul 24 2015
Court Rules That StemCells, Inc. Lacks Standing to Pursue Patent Infringement Suit Jul 23 2015
StemCells, Inc. Announces Webcast to Discuss Second Quarter 2015 Financial Results Jul 22 2015
StemCells, Inc. Announces Webcast to Discuss Second Quarter 2015 Financial Results Jul 22 2015
StemCells, Inc. Transplants First Patient in Phase II Clinical Trial for Dry Age-Related Macular... Jul 20 2015
StemCells, Inc. Transplants First Patient in Phase II Clinical Trial for Dry Age-Related Macular... Jul 20 2015
StemCells, Inc. Clinical Programs Overview and Progress Update Jul 09 2015
StemCells, Inc. Clinical Programs Overview and Progress Update Jul 09 2015
StemCells, Inc. to Participate at Cantor Fitzgerald's Inaugural Healthcare Conference Jul 01 2015
StemCells, Inc. to Participate at Cantor Fitzgerald's Inaugural Healthcare Conference Jul 01 2015
STEMCELLS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 29 2015
StemCells, Inc.'s Phase II Pathway Study for Cervical Spinal Cord Injury Approved by Health Canada Jun 26 2015
StemCells, Inc. Reports Top Line Results for Its Phase I/II Study in Dry Age Related Macular... Jun 26 2015
StemCells, Inc. Reports Top Line Results for Its Phase I/II Study in Dry Age Related Macular... Jun 26 2015
Edited Transcript of STEM earnings conference call or presentation 5-May-15 8:30pm GMT Jun 22 2015
StemCells, Inc.'s Phase II Pathway Study for Cervical Spinal Cord Injury Approved by Health Canada Jun 18 2015
STEMCELLS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year,... Jun 15 2015
STEMCELLS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 05 2015
Will StemCells (STEM) Continue to Surge Higher? - Tale of the Tape Jun 04 2015
StemCells, Inc. Announces Commencement of the Second Cohort of the Pathway(TM) Study in Cervical... Jun 04 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK